Clinical Trials Logo
  1. Home
  2. Cardio-Renal Syndrome
  3. NCT05053893

Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

Cardio-Renal Syndrome Clinical Trial

Official title:
A Randomized, Parallel Controlled Trial of Roxadustat Combined withSacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

Clinical Trial Summary

A randomized and parallel controlled trial design of comparing the new treatment group of Roxadustat combined with Sacubitril Valsartan Sodium Tablets with the traditional treatment group of recombinant human erythropoietin (EPO) combined with ACEI or ARB in Chinese patients with cardiorenal anemia syndrome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05053893
Study type Interventional
Source The Affiliated Hospital of Qingdao University
Contact Guangqun Xing, Doctor
Phone 18661802178
Email gqx99monash@163.com
Status Recruiting
Phase N/A
Start date September 22, 2021
Completion date September 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Recruiting NCT04170855 - Kidney Sodium Content in Cardiorenal Patients N/A
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Withdrawn NCT02085668 - Renal Denervation in Patients With Chronic Heart Failure N/A
Terminated NCT02772146 - A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure N/A
Recruiting NCT02846337 - Ultrafiltration Versus Medical Therapies in the Management of the Cardio Renal Syndrome N/A
Active, not recruiting NCT02502981 - Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD Phase 4
Recruiting NCT04947670 - A Prospective, Multicenter, Randomized, Blinded, Sham-controlled, Feasibility Study of Renal Denervation in Patients With Chronic Heart Failure N/A
Not yet recruiting NCT05368766 - Predictive Value of Venous Excess Ultrasound Score in Management of Cardiorenal Patients
Withdrawn NCT02959281 - Bioimpedance and Hand-held Echocardiographay for Clinical Decision-making in Treatment of Cardio-renal Syndrome Type I N/A
Completed NCT04407936 - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention
Completed NCT05050877 - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II
Recruiting NCT03628443 - Cardiorenal Risk Stratification Pilot Study
Recruiting NCT02343393 - Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study Phase 3
Completed NCT02664246 - Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method N/A
Completed NCT03219996 - Risk Factors for Predictors of In-hospital Death in Acute Fulminant Myocarditis N/A
Completed NCT04145635 - The Aortix CRS Pilot Study N/A
Completed NCT02405377 - Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy N/A
Recruiting NCT05677100 - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure N/A
Completed NCT02831907 - Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery N/A